The first case of Ochrobactrum intermedium bacteremia in a pediatric patient with malignant tumor

BMC Infectious Diseases

Table 2 Case reports of O. intermedium infection

Author/Year	Age (year)/sex	Diagnose	Underlying disease	Antibiotic regimen	Prognosis	References
Moller et al./1999	45/F	Liver abcess	Liver transplant	CIP/metronidazole	Improved	[7]
Apisarnthanarak et al./2005	74/M	Bacteraemia	Bladder cancer	IPM/CIP	Improved	[12]
Vaidya et al./2006	49/M	Pelvic abscess	Non	LVX/metronidazole	Improved	[11]
Dharne et al./2008	26/M	Non-ulcer dispepsia	Unknown	Unknown	Improved	[19]
Jacobs et al./2013	34/M	Endophthalmitis	Vitrectomy, lensectomy, removal of intraocular foreign body	Intravitreal MOX	Improved	[10]
Rodriguez-Villodres et al./2016	70/M	Prostatic abscess	Bladder cancer	CIP/cotrimoxazole	Improved	[8]
Bharucha et al./2016	23/M	Infective endocarditis	Renal failure	MEM/MIN	Improved	[9]
Hirai et al./2016	86/M	Bacteraemia	Cerebral infarction	MEM	Improved	[17]
Kassab et al./2021	84/F	Bacteraemia	Primary sclerosing cholangitis	MIN	Improved	[13]
Present case	2/M	Bacteraemia	Pineoblastoma	LVX/CAZ/SXT	Improved	–

CIP ciprofloxacin, IPM imipenem, LVX levofloxacin, MOX moxifloxacin, MEM meropenem, MIN minocycline, CAZ ceftazidime, SXT sulfamethoxazole–trimethoprim

ISSN: 1471-2334